"Monoclonal Antibodies: Revolutionizing Targeted Therapy and Biomedical Innovations" #sciencefather#researchawards#MonoclonalAntibodies#mAbs #Immunotherapy #CancerTreatment #Hybridoma #AntibodyEngineering
Monoclonal Antibodies π§¬π
Monoclonal antibodies (mAbs) are laboratory-produced molecules designed to mimic the immune system’s ability to fight diseases, particularly cancer, autoimmune disorders, and infectious diseases. They are engineered from a single B-cell clone, ensuring high specificity for a particular antigen. Unlike polyclonal antibodies, which recognize multiple epitopes, monoclonal antibodies target a single epitope, providing precise therapeutic effects.
Production Process ππ¬
- Antigen Selection – A specific antigen (e.g., a tumor marker) is identified for targeting.
- Immunization – Mice or other host animals are immunized with the antigen to stimulate B-cell production.
- Hybridoma Technology – B-cells from the immunized host are fused with immortal myeloma cells to create hybridomas, which produce identical monoclonal antibodies.
- Screening & Selection – Hybridomas are screened for high-affinity antibody production.
- Purification & Scaling – Antibodies are purified and mass-produced using bioreactors and cell culture technologies.
- Humanization & Modification – To reduce immune rejection, chimeric, humanized, or fully human monoclonal antibodies are developed.
Types of Monoclonal Antibodies π₯π§ͺ
✔ Murine mAbs – Derived from mouse cells, prone to human immune response.
✔ Chimeric mAbs – Partially humanized to reduce immunogenicity.
✔ Humanized mAbs – Mostly human, with only key antigen-binding regions from mice.
✔ Fully Human mAbs – Produced using transgenic mice or phage display, minimizing immune rejection.
Applications of Monoclonal Antibodies ππ
πΉ Cancer Therapy – Used in immunotherapy, targeting tumor antigens (e.g., rituximab for lymphoma).
πΉ Autoimmune Diseases – Modulate immune responses in diseases like rheumatoid arthritis (e.g., adalimumab).
πΉ Infectious Diseases – Neutralize pathogens, including COVID-19 (e.g., casirivimab & imdevimab).
πΉ Transplant Medicine – Prevent organ rejection by suppressing immune responses.
πΉ Diagnostic & Imaging – Used in disease detection via labeled monoclonal antibodies.
Future Advancements ππ¬
✅ Bispecific Antibodies – Bind to two different antigens simultaneously for enhanced therapy.
✅ Antibody-Drug Conjugates (ADCs) – Monoclonal antibodies linked to cytotoxic drugs for targeted cancer therapy.
✅ Nanobody Technology – Single-domain antibodies derived from camelids for improved tissue penetration.
See more info: http://biotechnologyscientist.
Nomination Link : https://
SOCIAL MEDIA
Facebook : https://www.facebook.com/
Twitter : https://x.com/DiyaLyra34020
Tumblr : https://www.tumblr.com/blog/
Blogger: https://www.blogger.com/u/1/
Linked in : https://www.linkedin.com/in/
Pinterest : https://in.pinterest.com/
#sciencefather#researchawards#
Comments
Post a Comment